Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Platinum Alfa sp. z o.o. is a venture capital fund based in Toruń, Poland, established to support early-stage and advanced technology projects. Founded as a continuation of the earlier Platinum Seed Incubator, the fund operates under the BRIdge Alfa program, part of the Operational Program Intelligent Development. This initiative aims to assist entrepreneurs in navigating the business landscape and commercializing research and development results.
Currently, Platinum Alfa focuses on sectors such as healthcare, biotech, AI, fintech, and consumer technology. The fund primarily targets projects at the early stages of development, specifically those with a Technology Readiness Level (TRL) of 2 to 5. As of now, the fund has a portfolio of seven companies, indicating its active engagement in fostering innovation.
Platinum Alfa's commitment to supporting personalized medical care is evident in its alignment with the National Intelligent Specializations, which include healthy society and biotechnological processes. The fund's strategic guidance and financial support aim to enhance the commercialization of innovative solutions in the healthcare sector.
Platinum Alfa specializes in personalized medical care, particularly in the e-Health and MEDtech sectors. The fund invests in projects that align with the National Intelligent Specializations, focusing on areas such as healthy society, biotechnology, advanced materials, sensors, and automation technologies. This targeted approach ensures that investments are made in sectors that are critical for the advancement of personalized medicine.
The fund primarily targets early-stage projects, specifically those with a Technology Readiness Level (TRL) of 2 to 5. This focus allows Platinum Alfa to support innovative ideas at their inception, providing the necessary resources to help entrepreneurs refine their business models and enhance their product offerings. The investment stages include pre-seed, seed, and seed-plus, catering to a wide range of early-stage ventures.
Platinum Alfa has invested in a diverse range of companies, showcasing its commitment to innovation in healthcare and technology. Notable projects in its portfolio include:
This portfolio reflects Platinum Alfa's focus on supporting innovative solutions that address real-world challenges in healthcare and technology.
Dr. Damian Andrzejewski: President and Director of Research and Development at Platinum Alfa. He has a background in research and development, focusing on innovative healthcare solutions.
Anna Mitros: Investment Director and Project Director. Anna brings extensive experience in managing investment projects and has a strong understanding of the healthcare sector.
Marek Kuźbicki: Commercialization Manager. Marek specializes in helping startups navigate the commercialization process, ensuring that innovative ideas reach the market effectively.
To pitch to Platinum Alfa, founders should use the contact email contact@platinumalfa.eu and include a detailed business plan in their deck. It is important to clearly outline the technology's potential impact and the team's qualifications. While there is no formal application portal, a well-structured email pitch is encouraged. Response times may vary, so founders should be prepared for potential follow-up communications.
Platinum Alfa operates under the BRIdge Alfa program, which supports research and development projects in the pre-seed phase through proof of concept funds. This program is part of the Operational Program Intelligent Development for the years 2014-2020, aimed at fostering innovation and commercialization of technology in Poland.
As of 2020, Platinum Alfa has been actively involved in supporting innovative health solutions through its BRIdge Alfa program. The fund's portfolio includes seven notable projects, indicating ongoing engagement in the healthcare and technology sectors. However, recent activity has been limited, and the fund may be in a wind-down phase following the conclusion of the EU's 2014-2020 program cycle.
What are Platinum Alfa's investment criteria?
Platinum Alfa invests in early-stage technology projects, particularly in the sectors of healthcare, biotech, AI, fintech, and consumer technology. The fund focuses on projects with a Technology Readiness Level (TRL) of 2 to 5.
How can I pitch to Platinum Alfa?
Founders can pitch their ideas by visiting the fund's website at platinumalfa.eu and using the contact email contact@platinumalfa.eu. It is advisable to include a detailed business plan and a clear explanation of the technology's potential impact.
What makes Platinum Alfa different from other investors?
Platinum Alfa focuses specifically on personalized medical care and aligns its investments with the National Intelligent Specializations. This targeted approach allows the fund to provide specialized support and guidance to its portfolio companies.
What is the geographic focus of Platinum Alfa?
The fund primarily invests in projects based in Europe, with a strong emphasis on Poland, aligning with the Polish National Smart Specializations.
What is the typical check size for investments?
While specific check sizes are not disclosed, Platinum Alfa typically invests in the pre-seed and seed stages, which generally involve smaller investment amounts compared to later-stage funding.
What kind of support does Platinum Alfa provide post-investment?
Platinum Alfa offers strategic guidance and financial support to its portfolio companies, helping them navigate the complexities of technology commercialization and refine their business models.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.